JACC: Advances Cardiology and Cardiovascular Medicine
Cardiovascular and Cerebrovascular Outcomes Risk Reduction Associated With Semaglutide vs Tirzepatide: Methodological Concerns
The publisher did not provide an abstract — full text is available via the link below.